中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
43期
22-23
,共2页
益肾活血方%金属蛋白酶-9(MMP-9)%高敏C-反应蛋白(hs-CRP)
益腎活血方%金屬蛋白酶-9(MMP-9)%高敏C-反應蛋白(hs-CRP)
익신활혈방%금속단백매-9(MMP-9)%고민C-반응단백(hs-CRP)
The tonifying kidney and promoting blood circulation%matrix metal oproteinase -9%high sensitivity C-reactive protein
目的：研究中药自拟益肾活血方对不稳定型心绞痛(胸痹心痛病)患者血清炎症因子的影响。方法62例确诊为不稳定型心绞痛患者随机分为研究组和对照组，对照组给予常规药物治疗，研究组在常规治疗的基础上再给予自拟中药益肾活血方，分别于治疗前和治疗后12周测患者(MMP-9)和(hs-CRP)浓度。结果12周后研究患者血清MMP-9和hs-CRP的治疗前明显下降(P＜0.05)。结论益肾活血方能有效降低不稳定心绞痛患者血清MMP-9和hs-CRP的浓度。
目的：研究中藥自擬益腎活血方對不穩定型心絞痛(胸痺心痛病)患者血清炎癥因子的影響。方法62例確診為不穩定型心絞痛患者隨機分為研究組和對照組，對照組給予常規藥物治療，研究組在常規治療的基礎上再給予自擬中藥益腎活血方，分彆于治療前和治療後12週測患者(MMP-9)和(hs-CRP)濃度。結果12週後研究患者血清MMP-9和hs-CRP的治療前明顯下降(P＜0.05)。結論益腎活血方能有效降低不穩定心絞痛患者血清MMP-9和hs-CRP的濃度。
목적：연구중약자의익신활혈방대불은정형심교통(흉비심통병)환자혈청염증인자적영향。방법62례학진위불은정형심교통환자수궤분위연구조화대조조，대조조급여상규약물치료，연구조재상규치료적기출상재급여자의중약익신활혈방，분별우치료전화치료후12주측환자(MMP-9)화(hs-CRP)농도。결과12주후연구환자혈청MMP-9화hs-CRP적치료전명현하강(P＜0.05)。결론익신활혈방능유효강저불은정심교통환자혈청MMP-9화hs-CRP적농도。
Objective To learn the effect of The tonifying kidney and promoting blood circulation on inflammatory factor in patients with unstable angina. Methods :62 patients diagnosed with unstable angina were randomly divided into treatment group and control group.The control group received conventional drug treatment.The treatment group were given the tonifying kidney and promoting blood circulation in addition to the conventional drug treatment. The inflammatory factor were measured . Results:The inflammatory factor decreased morn significantly after treatment (P <0.05) within the treatment group. Conclusion:The tonifying kidney and promoting blood circulation can effectively reduce the inflammatory factor in patients .
